Table of Content

1 Avastin (Bevacizumab) Biosimilars Market Overview
1.1 Product Overview and Scope of Avastin (Bevacizumab) Biosimilars
1.2 Avastin (Bevacizumab) Biosimilars Segment by Type
1.2.1 Global Avastin (Bevacizumab) Biosimilars Market Value Comparison by Type (2024-2034)
1.2.2 Cancers
1.2.3 AMD
1.3 Avastin (Bevacizumab) Biosimilars Segment by Application
1.3.1 Global Avastin (Bevacizumab) Biosimilars Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Avastin (Bevacizumab) Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Avastin (Bevacizumab) Biosimilars Revenue 2018-2029
1.4.2 Global Avastin (Bevacizumab) Biosimilars Sales 2018-2029
1.4.3 Global Avastin (Bevacizumab) Biosimilars Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Avastin (Bevacizumab) Biosimilars Market Competition by Manufacturers
2.1 Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Manufacturers (2018-2024)
2.2 Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Avastin (Bevacizumab) Biosimilars Average Price by Manufacturers (2018-2024)
2.4 Global Avastin (Bevacizumab) Biosimilars Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Avastin (Bevacizumab) Biosimilars, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Avastin (Bevacizumab) Biosimilars, Product Type & Application
2.7 Avastin (Bevacizumab) Biosimilars Market Competitive Situation and Trends
2.7.1 Avastin (Bevacizumab) Biosimilars Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Avastin (Bevacizumab) Biosimilars Players Market Share by Revenue
2.7.3 Global Avastin (Bevacizumab) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Avastin (Bevacizumab) Biosimilars Retrospective Market Scenario by Region
3.1 Global Avastin (Bevacizumab) Biosimilars Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Avastin (Bevacizumab) Biosimilars Global Avastin (Bevacizumab) Biosimilars Sales by Region: 2018-2029
3.2.1 Global Avastin (Bevacizumab) Biosimilars Sales by Region: 2018-2024
3.2.2 Global Avastin (Bevacizumab) Biosimilars Sales by Region: 2024-2029
3.3 Global Avastin (Bevacizumab) Biosimilars Global Avastin (Bevacizumab) Biosimilars Revenue by Region: 2018-2029
3.3.1 Global Avastin (Bevacizumab) Biosimilars Revenue by Region: 2018-2024
3.3.2 Global Avastin (Bevacizumab) Biosimilars Revenue by Region: 2024-2029
3.4 North America Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.4.1 North America Avastin (Bevacizumab) Biosimilars Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2029)
3.4.3 North America Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.5.1 Europe Avastin (Bevacizumab) Biosimilars Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2029)
3.5.3 Europe Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.6.1 Asia Pacific Avastin (Bevacizumab) Biosimilars Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2029)
3.6.3 Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.7.1 Latin America Avastin (Bevacizumab) Biosimilars Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2029)
3.7.3 Latin America Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.8.1 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2029)
3.8.3 Middle East and Africa Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Avastin (Bevacizumab) Biosimilars Sales by Type (2018-2029)
4.1.1 Global Avastin (Bevacizumab) Biosimilars Sales by Type (2018-2024)
4.1.2 Global Avastin (Bevacizumab) Biosimilars Sales by Type (2024-2029)
4.1.3 Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Type (2018-2029)
4.2 Global Avastin (Bevacizumab) Biosimilars Revenue by Type (2018-2029)
4.2.1 Global Avastin (Bevacizumab) Biosimilars Revenue by Type (2018-2024)
4.2.2 Global Avastin (Bevacizumab) Biosimilars Revenue by Type (2024-2029)
4.2.3 Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Type (2018-2029)
4.3 Global Avastin (Bevacizumab) Biosimilars Price by Type (2018-2029)
5 Segment by Application
5.1 Global Avastin (Bevacizumab) Biosimilars Sales by Application (2018-2029)
5.1.1 Global Avastin (Bevacizumab) Biosimilars Sales by Application (2018-2024)
5.1.2 Global Avastin (Bevacizumab) Biosimilars Sales by Application (2024-2029)
5.1.3 Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Application (2018-2029)
5.2 Global Avastin (Bevacizumab) Biosimilars Revenue by Application (2018-2029)
5.2.1 Global Avastin (Bevacizumab) Biosimilars Revenue by Application (2018-2024)
5.2.2 Global Avastin (Bevacizumab) Biosimilars Revenue by Application (2024-2029)
5.2.3 Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Application (2018-2029)
5.3 Global Avastin (Bevacizumab) Biosimilars Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Roche Avastin (Bevacizumab) Biosimilars Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Genentech
6.2.1 Genentech Corporation Information
6.2.2 Genentech Description and Business Overview
6.2.3 Genentech Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Genentech Avastin (Bevacizumab) Biosimilars Product Portfolio
6.2.5 Genentech Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Pfizer Avastin (Bevacizumab) Biosimilars Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sartorius
6.4.1 Sartorius Corporation Information
6.4.2 Sartorius Description and Business Overview
6.4.3 Sartorius Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sartorius Avastin (Bevacizumab) Biosimilars Product Portfolio
6.4.5 Sartorius Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Eli Lilly Avastin (Bevacizumab) Biosimilars Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Bayer Avastin (Bevacizumab) Biosimilars Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Amgen Avastin (Bevacizumab) Biosimilars Product Portfolio
6.7.5 Amgen Recent Developments/Updates
6.8 PlantForm
6.8.1 PlantForm Corporation Information
6.8.2 PlantForm Description and Business Overview
6.8.3 PlantForm Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.8.4 PlantForm Avastin (Bevacizumab) Biosimilars Product Portfolio
6.8.5 PlantForm Recent Developments/Updates
6.9 PharmaPraxis
6.9.1 PharmaPraxis Corporation Information
6.9.2 PharmaPraxis Description and Business Overview
6.9.3 PharmaPraxis Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.9.4 PharmaPraxis Avastin (Bevacizumab) Biosimilars Product Portfolio
6.9.5 PharmaPraxis Recent Developments/Updates
6.10 Samsung Bioepis
6.10.1 Samsung Bioepis Corporation Information
6.10.2 Samsung Bioepis Description and Business Overview
6.10.3 Samsung Bioepis Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Samsung Bioepis Avastin (Bevacizumab) Biosimilars Product Portfolio
6.10.5 Samsung Bioepis Recent Developments/Updates
6.11 Centus
6.11.1 Centus Corporation Information
6.11.2 Centus Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.11.3 Centus Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Centus Avastin (Bevacizumab) Biosimilars Product Portfolio
6.11.5 Centus Recent Developments/Updates
6.12 Cadila Pharmaceuticals
6.12.1 Cadila Pharmaceuticals Corporation Information
6.12.2 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.12.3 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product Portfolio
6.12.5 Cadila Pharmaceuticals Recent Developments/Updates
6.13 Dr Reddy's
6.13.1 Dr Reddy's Corporation Information
6.13.2 Dr Reddy's Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.13.3 Dr Reddy's Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Dr Reddy's Avastin (Bevacizumab) Biosimilars Product Portfolio
6.13.5 Dr Reddy's Recent Developments/Updates
6.14 Biocad
6.14.1 Biocad Corporation Information
6.14.2 Biocad Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.14.3 Biocad Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Biocad Avastin (Bevacizumab) Biosimilars Product Portfolio
6.14.5 Biocad Recent Developments/Updates
6.15 MAbxience
6.15.1 MAbxience Corporation Information
6.15.2 MAbxience Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.15.3 MAbxience Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.15.4 MAbxience Avastin (Bevacizumab) Biosimilars Product Portfolio
6.15.5 MAbxience Recent Developments/Updates
6.16 Hetero
6.16.1 Hetero Corporation Information
6.16.2 Hetero Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.16.3 Hetero Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Hetero Avastin (Bevacizumab) Biosimilars Product Portfolio
6.16.5 Hetero Recent Developments/Updates
6.17 Biocon
6.17.1 Biocon Corporation Information
6.17.2 Biocon Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.17.3 Biocon Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Biocon Avastin (Bevacizumab) Biosimilars Product Portfolio
6.17.5 Biocon Recent Developments/Updates
6.18 Kirin Biologics
6.18.1 Kirin Biologics Corporation Information
6.18.2 Kirin Biologics Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.18.3 Kirin Biologics Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Kirin Biologics Avastin (Bevacizumab) Biosimilars Product Portfolio
6.18.5 Kirin Biologics Recent Developments/Updates
6.19 Mylan
6.19.1 Mylan Corporation Information
6.19.2 Mylan Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.19.3 Mylan Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Mylan Avastin (Bevacizumab) Biosimilars Product Portfolio
6.19.5 Mylan Recent Developments/Updates
6.20 BeiGene
6.20.1 BeiGene Corporation Information
6.20.2 BeiGene Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.20.3 BeiGene Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.20.4 BeiGene Avastin (Bevacizumab) Biosimilars Product Portfolio
6.20.5 BeiGene Recent Developments/Updates
6.21 Innovent
6.21.1 Innovent Corporation Information
6.21.2 Innovent Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.21.3 Innovent Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Innovent Avastin (Bevacizumab) Biosimilars Product Portfolio
6.21.5 Innovent Recent Developments/Updates
6.22 Qilu Pharmaceutical
6.22.1 Qilu Pharmaceutical Corporation Information
6.22.2 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.22.3 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
6.22.5 Qilu Pharmaceutical Recent Developments/Updates
6.23 TOT BIOPHARM
6.23.1 TOT BIOPHARM Corporation Information
6.23.2 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.23.3 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.23.4 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Product Portfolio
6.23.5 TOT BIOPHARM Recent Developments/Updates
6.24 Luye Pharmaceutical
6.24.1 Luye Pharmaceutical Corporation Information
6.24.2 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.24.3 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
6.24.5 Luye Pharmaceutical Recent Developments/Updates
6.25 Henlius
6.25.1 Henlius Corporation Information
6.25.2 Henlius Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.25.3 Henlius Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Henlius Avastin (Bevacizumab) Biosimilars Product Portfolio
6.25.5 Henlius Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Avastin (Bevacizumab) Biosimilars Industry Chain Analysis
7.2 Avastin (Bevacizumab) Biosimilars Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Avastin (Bevacizumab) Biosimilars Production Mode & Process
7.4 Avastin (Bevacizumab) Biosimilars Sales and Marketing
7.4.1 Avastin (Bevacizumab) Biosimilars Sales Channels
7.4.2 Avastin (Bevacizumab) Biosimilars Distributors
7.5 Avastin (Bevacizumab) Biosimilars Customers
8 Avastin (Bevacizumab) Biosimilars Market Dynamics
8.1 Avastin (Bevacizumab) Biosimilars Industry Trends
8.2 Avastin (Bevacizumab) Biosimilars Market Drivers
8.3 Avastin (Bevacizumab) Biosimilars Market Challenges
8.4 Avastin (Bevacizumab) Biosimilars Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Avastin (Bevacizumab) Biosimilars Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Avastin (Bevacizumab) Biosimilars Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Avastin (Bevacizumab) Biosimilars Market Competitive Situation by Manufacturers in 2022
Table 4. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Avastin (Bevacizumab) Biosimilars Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Avastin (Bevacizumab) Biosimilars Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Avastin (Bevacizumab) Biosimilars Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Avastin (Bevacizumab) Biosimilars, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Avastin (Bevacizumab) Biosimilars, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Avastin (Bevacizumab) Biosimilars, Product Type & Application
Table 12. Global Key Manufacturers of Avastin (Bevacizumab) Biosimilars, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Avastin (Bevacizumab) Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Avastin (Bevacizumab) Biosimilars as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Avastin (Bevacizumab) Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2018-2024) & (K Units)
Table 18. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Region (2018-2024)
Table 19. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2024-2029) & (K Units)
Table 20. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Region (2024-2029)
Table 21. Global Avastin (Bevacizumab) Biosimilars Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region (2018-2024)
Table 23. Global Avastin (Bevacizumab) Biosimilars Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region (2024-2029)
Table 25. North America Avastin (Bevacizumab) Biosimilars Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2024) & (K Units)
Table 27. North America Avastin (Bevacizumab) Biosimilars Sales by Country (2024-2029) & (K Units)
Table 28. North America Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Avastin (Bevacizumab) Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Avastin (Bevacizumab) Biosimilars Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2024) & (K Units)
Table 32. Europe Avastin (Bevacizumab) Biosimilars Sales by Country (2024-2029) & (K Units)
Table 33. Europe Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Avastin (Bevacizumab) Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Avastin (Bevacizumab) Biosimilars Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Avastin (Bevacizumab) Biosimilars Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Avastin (Bevacizumab) Biosimilars Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Avastin (Bevacizumab) Biosimilars Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Avastin (Bevacizumab) Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Avastin (Bevacizumab) Biosimilars Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Avastin (Bevacizumab) Biosimilars Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Avastin (Bevacizumab) Biosimilars Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Avastin (Bevacizumab) Biosimilars Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Avastin (Bevacizumab) Biosimilars Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) by Type (2018-2024)
Table 51. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) by Type (2024-2029)
Table 52. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Type (2018-2024)
Table 53. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Type (2024-2029)
Table 54. Global Avastin (Bevacizumab) Biosimilars Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Avastin (Bevacizumab) Biosimilars Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Type (2018-2024)
Table 57. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Type (2024-2029)
Table 58. Global Avastin (Bevacizumab) Biosimilars Price (USD/Unit) by Type (2018-2024)
Table 59. Global Avastin (Bevacizumab) Biosimilars Price (USD/Unit) by Type (2024-2029)
Table 60. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) by Application (2018-2024)
Table 61. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) by Application (2024-2029)
Table 62. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Application (2018-2024)
Table 63. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Application (2024-2029)
Table 64. Global Avastin (Bevacizumab) Biosimilars Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Avastin (Bevacizumab) Biosimilars Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Application (2018-2024)
Table 67. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Application (2024-2029)
Table 68. Global Avastin (Bevacizumab) Biosimilars Price (USD/Unit) by Application (2018-2024)
Table 69. Global Avastin (Bevacizumab) Biosimilars Price (USD/Unit) by Application (2024-2029)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Roche Avastin (Bevacizumab) Biosimilars Product
Table 74. Roche Recent Developments/Updates
Table 75. Genentech Corporation Information
Table 76. Genentech Description and Business Overview
Table 77. Genentech Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Genentech Avastin (Bevacizumab) Biosimilars Product
Table 79. Genentech Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Pfizer Avastin (Bevacizumab) Biosimilars Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Sartorius Corporation Information
Table 86. Sartorius Description and Business Overview
Table 87. Sartorius Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Sartorius Avastin (Bevacizumab) Biosimilars Product
Table 89. Sartorius Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Eli Lilly Avastin (Bevacizumab) Biosimilars Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Bayer Avastin (Bevacizumab) Biosimilars Product
Table 99. Bayer Recent Developments/Updates
Table 100. Amgen Corporation Information
Table 101. Amgen Description and Business Overview
Table 102. Amgen Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Amgen Avastin (Bevacizumab) Biosimilars Product
Table 104. Amgen Recent Developments/Updates
Table 105. PlantForm Corporation Information
Table 106. PlantForm Description and Business Overview
Table 107. PlantForm Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. PlantForm Avastin (Bevacizumab) Biosimilars Product
Table 109. PlantForm Recent Developments/Updates
Table 110. PharmaPraxis Corporation Information
Table 111. PharmaPraxis Description and Business Overview
Table 112. PharmaPraxis Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. PharmaPraxis Avastin (Bevacizumab) Biosimilars Product
Table 114. PharmaPraxis Recent Developments/Updates
Table 115. Samsung Bioepis Corporation Information
Table 116. Samsung Bioepis Description and Business Overview
Table 117. Samsung Bioepis Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Samsung Bioepis Avastin (Bevacizumab) Biosimilars Product
Table 119. Samsung Bioepis Recent Developments/Updates
Table 120. Centus Corporation Information
Table 121. Centus Description and Business Overview
Table 122. Centus Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Centus Avastin (Bevacizumab) Biosimilars Product
Table 124. Centus Recent Developments/Updates
Table 125. Cadila Pharmaceuticals Corporation Information
Table 126. Cadila Pharmaceuticals Description and Business Overview
Table 127. Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product
Table 129. Cadila Pharmaceuticals Recent Developments/Updates
Table 130. Dr Reddy's Corporation Information
Table 131. Dr Reddy's Description and Business Overview
Table 132. Dr Reddy's Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Dr Reddy's Avastin (Bevacizumab) Biosimilars Product
Table 134. Dr Reddy's Recent Developments/Updates
Table 135. Biocad Corporation Information
Table 136. Biocad Description and Business Overview
Table 137. Biocad Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Biocad Avastin (Bevacizumab) Biosimilars Product
Table 139. Biocad Recent Developments/Updates
Table 140. MAbxience Corporation Information
Table 141. MAbxience Description and Business Overview
Table 142. MAbxience Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. MAbxience Avastin (Bevacizumab) Biosimilars Product
Table 144. MAbxience Recent Developments/Updates
Table 145. Hetero Corporation Information
Table 146. Hetero Description and Business Overview
Table 147. Hetero Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Hetero Avastin (Bevacizumab) Biosimilars Product
Table 149. Hetero Recent Developments/Updates
Table 150. Biocon Corporation Information
Table 151. Biocon Description and Business Overview
Table 152. Biocon Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Biocon Avastin (Bevacizumab) Biosimilars Product
Table 154. Biocon Recent Developments/Updates
Table 155. Kirin Biologics Corporation Information
Table 156. Kirin Biologics Description and Business Overview
Table 157. Kirin Biologics Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. Kirin Biologics Avastin (Bevacizumab) Biosimilars Product
Table 159. Kirin Biologics Recent Developments/Updates
Table 160. Mylan Corporation Information
Table 161. Mylan Description and Business Overview
Table 162. Mylan Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Mylan Avastin (Bevacizumab) Biosimilars Product
Table 164. Mylan Recent Developments/Updates
Table 165. BeiGene Corporation Information
Table 166. BeiGene Description and Business Overview
Table 167. BeiGene Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. BeiGene Avastin (Bevacizumab) Biosimilars Product
Table 169. BeiGene Recent Developments/Updates
Table 170. Innovent Corporation Information
Table 171. Innovent Description and Business Overview
Table 172. Innovent Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 173. Innovent Avastin (Bevacizumab) Biosimilars Product
Table 174. Innovent Recent Developments/Updates
Table 175. Qilu Pharmaceutical Corporation Information
Table 176. Qilu Pharmaceutical Description and Business Overview
Table 177. Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 178. Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Product
Table 179. Qilu Pharmaceutical Recent Developments/Updates
Table 180. TOT BIOPHARM Corporation Information
Table 181. TOT BIOPHARM Description and Business Overview
Table 182. TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 183. TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Product
Table 184. TOT BIOPHARM Recent Developments/Updates
Table 185. Luye Pharmaceutical Corporation Information
Table 186. Luye Pharmaceutical Description and Business Overview
Table 187. Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 188. Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Product
Table 189. Luye Pharmaceutical Recent Developments/Updates
Table 190. Henlius Corporation Information
Table 191. Henlius Description and Business Overview
Table 192. Henlius Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 193. Henlius Avastin (Bevacizumab) Biosimilars Product
Table 194. Henlius Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Avastin (Bevacizumab) Biosimilars Distributors List
Table 198. Avastin (Bevacizumab) Biosimilars Customers List
Table 199. Avastin (Bevacizumab) Biosimilars Market Trends
Table 200. Avastin (Bevacizumab) Biosimilars Market Drivers
Table 201. Avastin (Bevacizumab) Biosimilars Market Challenges
Table 202. Avastin (Bevacizumab) Biosimilars Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Avastin (Bevacizumab) Biosimilars
Figure 2. Global Avastin (Bevacizumab) Biosimilars Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Avastin (Bevacizumab) Biosimilars Market Share by Type in 2022 & 2029
Figure 4. Cancers Product Picture
Figure 5. AMD Product Picture
Figure 6. Global Avastin (Bevacizumab) Biosimilars Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Avastin (Bevacizumab) Biosimilars Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Avastin (Bevacizumab) Biosimilars Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Avastin (Bevacizumab) Biosimilars Market Size (2018-2029) & (US$ Million)
Figure 13. Global Avastin (Bevacizumab) Biosimilars Sales (2018-2029) & (K Units)
Figure 14. Global Avastin (Bevacizumab) Biosimilars Average Price (USD/Unit) & (2018-2029)
Figure 15. Avastin (Bevacizumab) Biosimilars Report Years Considered
Figure 16. Avastin (Bevacizumab) Biosimilars Sales Share by Manufacturers in 2022
Figure 17. Global Avastin (Bevacizumab) Biosimilars Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Avastin (Bevacizumab) Biosimilars Players: Market Share by Revenue in 2022
Figure 19. Avastin (Bevacizumab) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Avastin (Bevacizumab) Biosimilars Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2018-2029)
Figure 22. North America Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2018-2029)
Figure 23. United States Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2018-2029)
Figure 26. Europe Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2018-2029)
Figure 27. Germany Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region (2018-2029)
Figure 34. China Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2018-2029)
Figure 44. Latin America Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Avastin (Bevacizumab) Biosimilars by Type (2018-2029)
Figure 54. Global Revenue Market Share of Avastin (Bevacizumab) Biosimilars by Type (2018-2029)
Figure 55. Global Avastin (Bevacizumab) Biosimilars Price (USD/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Avastin (Bevacizumab) Biosimilars by Application (2018-2029)
Figure 57. Global Revenue Market Share of Avastin (Bevacizumab) Biosimilars by Application (2018-2029)
Figure 58. Global Avastin (Bevacizumab) Biosimilars Price (USD/Unit) by Application (2018-2029)
Figure 59. Avastin (Bevacizumab) Biosimilars Value Chain
Figure 60. Avastin (Bevacizumab) Biosimilars Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed